Cresco Labs is trading 6.5% up at $0.78, based on the provided live price context; no clear catalyst has been identified.
- No major company-specific announcement dated August 28, 2026 was identified; the latest prominent catalyst was its August 6 second-quarter report, showing $173 million revenue and $40 million adjusted EBITDA.
- The broader market is slightly defensive, while consumer staples are lower, neither clearly explaining the gain.
- The move remains unattributed pending delayed filings, social-media activity, or sector-specific cannabis news.